In experiments on NPRA downregulation, NPRA-deficient C57BL/6 mice showed significant anti-cancer activity [14], and NP73-120, which is the NH2-terminal peptide of ANP pro-hormone that can restrain the expression of NPRA, was used to investigate the effect in human lung cancer tumorigenesis. This evidence concerns the gene NPPA and lung cancer.